AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 387 filers reported holding AVANOS MED INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $40,719,000 | -37.3% | 1,174,483 | -43.6% | 0.18% | -40.8% |
| Q3 2021 | $64,987,000 | -31.5% | 2,082,903 | -20.1% | 0.31% | -31.0% |
| Q2 2021 | $94,818,000 | -25.6% | 2,607,033 | -10.5% | 0.45% | -32.0% |
| Q1 2021 | $127,379,000 | -20.0% | 2,912,188 | -16.1% | 0.66% | -27.5% |
| Q4 2020 | $159,246,000 | +41.8% | 3,470,935 | +2.7% | 0.91% | +19.6% |
| Q3 2020 | $112,308,000 | +13.9% | 3,380,740 | +0.8% | 0.76% | +8.1% |
| Q2 2020 | $98,564,000 | +6.6% | 3,353,655 | -2.4% | 0.71% | -15.1% |
| Q1 2020 | $92,488,000 | -17.7% | 3,434,370 | +3.0% | 0.83% | +1.5% |
| Q4 2019 | $112,366,000 | +16.2% | 3,334,297 | +29.1% | 0.82% | +3.1% |
| Q3 2019 | $96,721,000 | -9.7% | 2,581,982 | +5.1% | 0.80% | -11.5% |
| Q2 2019 | $107,086,000 | +4.5% | 2,455,532 | +2.2% | 0.90% | +0.6% |
| Q1 2019 | $102,517,000 | +9.1% | 2,401,987 | +14.5% | 0.89% | -6.4% |
| Q4 2018 | $93,968,000 | -12.4% | 2,097,972 | +34.0% | 0.96% | +0.4% |
| Q3 2018 | $107,271,000 | – | 1,565,996 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |